Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis

Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis

Introduction: Various pharmacological treatments are available for preterm infants with patent ductus arteriosus (PDA), but their risks and benefits are controversial. This study aimed to identify the best treatment for PDA using network meta-analysis (NMA) and risk-benefit assessment (RBA). Methods...

Full description

Bibliographic Details
Main Authors:	Sudarat Eursiriwan, Chusak Okascharoen, Sakda Arj-Ong Vallibhakara, Oraluck Pattanaprateep, Pawin Numthavaj, John Attia, Ammarin Thakkinstian
Format:	Article
Language:	English
Published:	Karger Publishers 2022-10-01
Series:	Biomedicine Hub
Subjects:	patent ductus arteriosus preterm hemodynamically significant patent ductus arteriosus risk-benefit analysis indomethacin ibuprofen acetaminophen
Online Access:	https://www.karger.com/Article/FullText/526318

Similar Items

Comparison of oral acetaminophen with oral ibuprofen on closure of symptomatic patent ductus arteriosus in preterm neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01)

Comparison of gastrointestinal complications of paracetamol and ibuprofen in the management of infants with patent ductus arteriosus: A randomized clinical trial study
by: Gohar Shahmirzadi, et al.
Published: (2021-01-01)

Comparison of Therapeutic Effects and Side Effects of Oral Ibuprofen and Indomethacin on the Closure of Patent Ductus Arteriosus in Premature Infants
by: P Sadeghi-Moghaddam, et al.
Published: (2017-09-01)

Positive tendency toward synchronous use of acetaminophen and ibuprofen in treating patients with patent ductus arteriosus
by: Roya Oboodi, et al.
Published: (2020-09-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01)

Evaluation the Effectiveness of Ibuprofen in Improving Patent Ductus Arteriosus
by: Maryam Beheshtifard, et al.
Published: (2021-09-01)

Comparison of Oral Paracetamol with Oral Ibuprofen in Closing Patent Ductus Arteriosus in Premature Neonates: A Randomized Controlled Trial
by: Mahmoud Samadi, et al.
Published: (2022-04-01)

Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation
by: Jannatdoust Abdollah, et al.
Published: (2014-12-01)

Different doses of ibuprofen in the treatment of patent ductus arteriosus: a randomized clinical trial
by: Jafari Fesharaki H, et al.
Published: (2012-11-01)

PATENT DUCTUS ARTERIOSUS CLOSURE: EXPERIENCE FROM A TERTIARY REFERRAL CENTER
by: Diogo Remi Oliveira Faim, et al.
Published: (2020-11-01)

Patent ductus arteriosus (PDA): Recent recommendations for to close or not to close
by: Yasemin Ezgi Köstekci, et al.
Published: (2024-03-01)

Early or Late Surgical Ligation of Medical Refractory Patent Ductus Arteriosus in Premature Infants
by: Chien-Chou Hsiao, et al.
Published: (2009-01-01)

Surgical Treatment of Patent Ductus Arteriosus by Combined Ligation and ClippingSomchai Waikittipong
by: Somchai Waikittipong
Published: (2011-02-01)

Comparison of two dose regimens of ibuprofen for the closure of patent ductus arteriosus in preterm newborns
by: Laura Vargas Dornelles, et al.
Published: (2016-05-01)

Patent ductus arteriosus treatment in preterm neonates, which is the drug of choice paracetamol vs ibuprofen?
by: Reham S Abd Al Hamid
Published: (2020-01-01)

High Rate of False Negative Diagnosis of Silent Patent Ductus Arteriosus on the Chest CT with 3 mm Slice-Thickness, Suggesting the Need for Analysis with Thinner Slice Thickness
by: Dongjun Lee, et al.
Published: (2021-07-01)

“Clinical Profile of Neonates with Patent Ductus Arteriosus and Factors Predicting Prolonged Paracetamol Treatment and Outcome” – A retrospective Study
by: K Shilpa, et al.
Published: (2021-01-01)

Efficacy and complications of oral ibuprofen and intravenous acetaminophen in closure of patent ductus arteriosus of preterm neonates
by: Semira Mehralizadeh, et al.
Published: (2019-11-01)

Prophylactic teatment with oral paracetamol for patent ductus arteriosus in preterm infants: a randomized clinical trial
by: Parvin Akbari Asbagh, et al.
Published: (2015-05-01)

Management of Patent Ductus Arteriosus in Term or Near-term Neonates With Respiratory Distress
by: Yu-Chen Lin, et al.
Published: (2010-06-01)

Low-dose intravenous acetaminophen versus oral ibuprofen for the closure of patent ductus arteriosus in premature neonates
by: Mehdi Ghaderian, et al.
Published: (2019-01-01)

Comparison of the Efficacy and Complications of Oral versus Intravenous Ibuprofen in Low-birth-weight Neonates with Patent Ductus Arteriosus: A Retrospective Cohort Study
by: Yazdan Ghandi, et al.
Published: (2022-10-01)

Comparison of oral ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants
by: Eun Mi Yang, et al.
Published: (2013-01-01)

Oral acetaminophen administration for patent ductus arteriosus (PDA) closure in preterm neonates
by: Mahmood Samadi, et al.
Published: (2021-08-01)

Subaortic membrane with patent ductus arteriosus
by: Nishes Basnet, et al.
Published: (2017-11-01)

Patent ductus arteriosus: peculiarities of early neonatal, postnatal diagnostics, clinical manifestations, treatment and prognosis
by: K.A. Kalashnikova, et al.
Published: (2017-03-01)

Safety and Feasibility of Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-/Ibuprofen-Resistant or -Contraindicated Preterm Infants: A Case Series
by: Ayumi Oshima, et al.
Published: (2020-01-01)

Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants
by: Demet Terek, et al.
Published: (2014-01-01)

Efficacy of Paracetamol in Closure of Ductus Arteriosus in Infants under 32 Weeks of Gestation
by: Ines Tofe, et al.
Published: (2018-02-01)

Efficacy and Safety of Paracetamol for Patent Ductus Arteriosus Closure in Preterm Infants: An Updated Systematic Review and Meta-Analysis
by: Yingqi Xiao, et al.
Published: (2020-02-01)

Patent ductus arteriosus with a rare hand anomaly
by: Y Ramesh Bhat, et al.
Published: (2022-01-01)

Diameter of the ductus arteriosus as a predictor of patent ductus arteriosus (PDA)
by: Nowak Dariusz, et al.
Published: (2011-08-01)

Physiological marker and surgical ligation of patent ductus arteriosus in neonates
by: Behrouz Banieghbal
Published: (2016-01-01)

Late Complication After Transcatheter Closure of Patent Ductus Arteriosus
by: Alessandro Salustri, MD, PhD, et al.
Published: (2019-10-01)

The efficacy and safety of oral paracetamol versus oral ibuprofen for patent ductus arteriosus closure in preterm neonates – A systematic review and meta-analysis
by: Raymond Pranata, et al.
Published: (2020-05-01)

Oral Ibuprofen versus Intravenous Indomethacin for Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
by: Cheng Han Lee, et al.
Published: (2012-12-01)

Personalized Evidence-Based Management of Patent Ductus Arteriosus in Preterm Infants
by: Belinda Chan, et al.
Published: (2023-12-01)

The strategy of paracetamol (acetaminophen) use in closing patent ductus arteriosus in premature neonates.
by: Khaleel I. ALSuwayfee
Published: (2016-10-01)

Repeated Courses of Oral Ibuprofen in Premature Infants with Patent Ductus Arteriosus: Efficacy and Safety
by: Haşim Olgun, et al.
Published: (2017-02-01)

Management of Patent Ductus Arteriosus in Premature Infants in 2020
by: Sarah Parkerson, et al.
Published: (2021-02-01)